This suggests that β-amyloid abnormalities, or other inflammatory triggers, could promote the movement of SRRM2 and PNN to the cytoplasm, promote CS formation, and lead to increased tau aggregate growth. This evidence concerns the gene MAPT and Cowden syndrome 1.